Issues related to corporate and international taxation and issues related to OECD negotiations on the taxation of global income, including tax code sections 951A, 250, 163(j), 55, 56A, and 41. Issues related to the amortization of research and experimentation expenses, including tax code section 174. Issues related to foreign tax credits, including T.D. 9959.
Duration: April 1, 2020
to
April 28, 2023
General Issues: Taxation/Internal Revenue Code
Spending: about $155,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2020: U.S. Senate, House of Representatives
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Regina Mahony Senior Policy Advisor, Rep. Cal Dooley; Senior Policy Advisor, House Democratic Whip Steny H Hoyer; House Majority Leader Steny H Hoyer
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
2nd Quarter, 2023
DOMER CONSULTING, LLC terminated an engagement in which they represented The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma on May 15, 2023.
Original Filing: 301470999.xml
1st Quarter, 2023
In Q1, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $20,000. The report was filed on April 20, 2023.
Original Filing: 301463981.xml
Lobbying Issues
Issues related to corporate and international taxation and issues related to OECD negotiations on the taxation of global income, including tax code sections 951A, 250, 163(j), 55, 56A, and 41. Issues related to the amortization of research and experimentation expenses, including tax code section 174. Issues related to foreign tax credits, including T.D. 9959.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2022
In Q4, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435235.xml
Lobbying Issues
Issues related to corporate and international taxation, including tax code sections 951A, 250, 245A, 163, 59A, 55 and 56A. Issues related to the amortization of research and experimentation expenses, HR 1304 and tax code section 174. Issues related to OECD negotiations on the taxation of global income. Issues related to foreign tax credits including TD 9959.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2022
In Q3, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on Oct. 17, 2022.
Original Filing: 301405840.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250, 245A, 163, and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico. Issues related to the amortization of research and experimentation expenses, HR 1304. Issues related to OECD negotiations on the taxation of global income. Issues related to H.R. 5376, the Build Back Better Act, including sections 138101, 138111, 138121, 138124, 138126, 138127, 138128, 138131, and 138516. Issues related to foreign tax credits including TD 9959. Issues related to HR 5376 Inflation Reduction Act including section 10101.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2022
In Q2, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on July 19, 2022.
Original Filing: 301385436.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250, 245A, 163, and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico. Issues related to the amortization of research and experimentation expenses, HR 1304. Issues related to OECD negotiations on the taxation of global income. Issues related to H.R. 5376, the Build Back Better Act, including sections 138101, 138111, 138121, 138124, 138126, 138127, 138128, 138131, and 138516. Issues related to foreign tax credits including TD 9959.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2022
In Q1, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on April 19, 2022.
Original Filing: 301360209.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250, 245A, and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico. Issues related to the amortization of research and experimentation expenses, HR 1304. Issues related to OECD negotiations on the taxation of global income. Issues related to H.R. 5376, the Build Back Better Act, including sections 138101, 138111, 138121, 138124, 138126, 138127, 138128, 138131, and 138516. Issues related to foreign tax credits including TD 9959.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2021
In Q4, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $20,000. The report was filed on Jan. 18, 2022.
Original Filing: 301326062.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250, 245A, and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico. Issues related to the amortization of research and experimentation expenses, HR 1304. Issues related to OECD negotiations on the taxation of global income. Issues related to H.R. 5376, the Build Back Better Act, including sections 138101, 138111, 138121, 138124, 138126, 138127, 138128, 138131, and 138516.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2021
In Q3, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $20,000. The report was filed on Oct. 19, 2021.
Original Filing: 301304818.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250, 245A, and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico. Issues related to the amortization of research and experimentation expenses, HR 1304. Issues related to OECD negotiations on the taxation of global income. Issues related to H.R. 5376, the Build Back Better Act, including sections 138101, 138111, 138121, 138124, 138126, 138127, 138128, 138131.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2021
In Q2, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on July 19, 2021.
Original Filing: 301282370.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250 and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico, and issues related to the repatriation of intellectual property. Issues related to the amortization of research and experimentation expenses. Issues related to OECD negotiations on the taxation of global income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
1st Quarter, 2021
In Q1, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on April 20, 2021.
Original Filing: 301267134.xml
Lobbying Issues
Issues related to corporate and international taxation, including issues related to corporate tax rates, issues related to the taxation of foreign income, including tax code sections 951A, 250 and 59A. Issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico, and issues related to the repatriation of intellectual property. Issues related to the amortization of research and experimentation expenses. Issues related to OECD negotiations on the taxation of global income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
4th Quarter, 2020
In Q4, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $10,000. The report was filed on Jan. 19, 2021.
Original Filing: 301235644.xml
Lobbying Issues
Issues related to corporate and international tax, including issues related to corporate tax rates, issues related to the taxation of foreign income, tax code sections 951A and 954(c)(6), issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico, and issues related to the repatriation of intellectual property (H.R. 7749). Issues related to the creditability of Puerto Rico excise taxes. (IRS REG-101657-20 - Guidance Related to the Foreign Tax Credit; Clarification of Foreign-Derived Intangible Income). Issues related to the amortization of research and experimentation expenses. Issues related to OECD negotiations on the taxation of global income
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
3rd Quarter, 2020
In Q3, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $20,000. The report was filed on Oct. 19, 2020.
Original Filing: 301213798.xml
Lobbying Issues
Issues related to corporate and international tax, including issues related to rates, tax code section 951A, issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico, and issues related to the repatriation of intellectual property (HR 7749). Issues related to the creditability of Puerto Rico excise taxes. OECD negotiations on the taxation of global income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
2nd Quarter, 2020
In Q2, DOMER CONSULTING, LLC lobbied for The Washington Tax & Public Policy Group o/b/o Alliance for Biopharma , earning $5,000. The report was filed on July 20, 2020.
Original Filing: 301197913.xml
Lobbying Issues
Issues related to corporate and international tax, including issues related to the taxation of manufacturing income and capital investment in the United States and Puerto Rico and issues related to the repatriation of intellectual property. Issues related to OECD negotiations on the taxation of global income.
Agencies Lobbied
U.S. Senate
Type of Issue
Taxation/Internal Revenue Code
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...